reason report weekli
broad market index declin
week versu increas result
perform gap narrow year-to-d medic
devic hospit suppli index continu lag broad market
under-perform modest
versu year-to-d gain
week review tuesday juli rate announc
posit data largest real-world studi to-dat urolift
use treatment bph specif retrospect
studi examin result patient receiv urolift
treatment two year across site north america
australia found result consist previous report
control clinic trial importantli studi serv support
favor view relat growth prospect urolift system
estim increas million
contribut report total revenu
also tuesday o/v rate announc appoint
david mowri posit chief execut offic effect
immedi jason richey compani interim ceo
appoint role presid prior join mr mowri
recent serv presid ceo vyair medic
rate privat well presid ceo tornier inc
acquir wright medic rate
billion furthermor mr mowri serv presid
covidien rate neurovascular divis prior join
tornier inc addit pre-announc compani
financi result exceed consensu growth estim
compani revenu forecast announc full financi result
august market close encourag
addit mowri oper expertis also astut
retent elev jason richey
dividend per common share payabl august
sharehold record juli
o/v rate issu custom servic notic exist user
notifi effect august user would longer
import disclosur analyst certif page report report constitut compendium report cover six
subject compani stephen inc choos provid specif disclosur compani mention refer
access current disclosur compani report client refer
contact stephen inc repres addit inform
abl place devic order directli altern depend individu insur provid
would either receiv cgm suppli via local pharmaci pbm channel via durabl medic equip
dme provid rate unit state medic suppli rate privat view
notic favor stand improv eas access wearer also reduc associ back-
offic cost compani
friday juli patent trial appeal board ptab determin a/ demonstr
reason likelihood compani challeng claim e/v rate patent unpatent
result ptab institut inter part review challeng claim ground petit recal
administr law judg intern trade commiss itc previous determin
patent claim assert valid howev itc rule preclus effect forum
 ptab
notabl outsid coverag agamatrix inc rate privat announc conjunct waveform
technolog inc rate privat subsidiari agamatrix hold llc compani rais
million capit specif compani use capit repay debt increas product
capac product develop clinic trial initi commerci waveform cgm
europ fda clearanc
monday juli biotronik rate privat announc compani receiv clearanc compani
biomonitor inject cardiac monitor icm specif icm design help patient irregular
heart rhythm track arrhythmia deliv signal physician importantli third gener icm
smaller second gener offer increas signal qualiti oper patient app
also monday vantag mobil intern rate privat numot corp rate privat
announc compani collabor increas awar mobil solut domest wheelchair
user specif program integr vantag mobil expertis convert car wheelchair
friendli numot line wheelchair network locat across compani recent
complet pilot program select locat plan expand program nation scale come month
lastli monday district judg amit mehta block trump administr rule requir pharmaceut
compani includ list price prescript medic televis ad administr hope pass
rule order increas transpar lower cost medic
tuesday juli procyrion inc rate privat announc complet million seri round
led bluebird ventur recal procyrion develop compani aortix system percutan blood pump
patient heart failur worsen kidney function latest round invest support procyrion effort
fda applic compani pivot trial
wednesday juli freseniu medic rate fm announc compani pleas trump
administr initi increas earli detect incentiv kidney donat increas oversight non-
profit collect center expand home dialysi instead in-clin treatment
thursday juli presid trump announc administr proceed curb pharmaceut rebat
receiv middlemen medicar follow push-back rebat rule would result medicar premium
cost feder govern billion year
note dollar million except per share data ep elgx nxtm
fulli tax pro forma
rate stephen inc overweight equal-weight underweight volatil susp suspend
percentag chang price
cal corporati
cal corporati
insul et corporati
danah corporati
ti surgi cal inc
compani document stephen inc estim rate
stephen inc otherwis estim base upon consensu
non-cov compani mention list figur page
analyst primarili respons prepar content report certifi view express report
accur reflect analyst person view subject compani secur ii part analyst compens
directli indirectli relat specif recommend view express analyst report
